Patent ID: 11862311
Assignee: DAXOR CORP.
Field: Measurement (Instruments)
Classification: CPC G  A | IPC A  G

Claim 0:
1. A method of treating a patient for correction of blood volume, comprising:
A) receiving a treatment recommendation based on an analysis of the patient's blood, wherein the analysis was conducted using a system for automatically analyzing blood of a human patient and for providing a quantified patient-individualized treatment for correction of blood volume in patient conditions where knowledge of patient blood volume influences treatment decisions, the system comprising a concentration counter configured to analyze one or more samples, a user interface operatively connected to the concentration counter and configured for entry and display of information, and one or more processors operatively coupled to a memory and configured to execute programmed instructions stored in the memory to carry out a method comprising the steps of:
(a) the concentration counter collecting at least one tracer count related to the concentration of a tracer within samples of blood from the human patient;
(b) the one or more processors calculating from the tracer count a blood volume (BV), plasma volume (PV), and red cell volume (RCV) for the patient;
(c) inputting patient descriptive data to the one or more processors;
(d) the one or more processors calculating from the patient descriptive data an ideal blood volume (iBV), ideal plasma volume (iPV), and ideal red cell volume (iRCV) for the patient;
(e) one or more processors providing a quantified patient-individualized treatment recommendation based on the patient's blood volume as expressed by the values calculated in steps (b) and (d), and protocol-derived rules stored within the system; and
(f) displaying, by the one or more processors, at the user interface, the treatment recommendation of step (e),
wherein the treatment recommendation is one or more of:
administration of saline or saline-equivalent fluids, plasma or oncotic-support fluids to a patient with low BV,
removal of fluids via dialysis or ultrafiltration from a patient with high BV,
administration of packed red blood cells, whole blood, or platelets to a patient with low RCV,
removal of red blood cells from a patient with high RCV,
removal of whole blood from a patient with high RCV via therapeutic phlebotomy,
stopping or lowering the dose of a diuretic drug for a patient with low BV, and
administering or increasing the dose of a diuretic drug for a patient with high BV; and

B) administering treatment to the patient in accordance with the treatment recommendation;
wherein the treatment is one or more of:
administering saline or saline-equivalent fluids, plasma or oncotic-support fluids to a patient with low BV,
removing fluids via dialysis or ultrafiltration from a patient with high BV,
administering packed red blood cells, whole blood, or platelets to a patient with low RCV,
removing red blood cells from a patient with high RCV via erythrocytapheresis,
removing whole blood from a patient with high RCV patient via therapeutic phlebotomy,
stopping or lowering the dose of a diuretic drug for a patient with low BV, and
administering or increasing the dose of a diuretic drug for a patient with high BV.